Latest Stories
Uncategorized
AI Drug Discovery Licensing Deals Hit $47.1 Billion in Just the First Half of 2026
AI drug discovery licensing deals hit $47.1 billion in the first half of 2026, already surpassing all of 2025, even as no AI-discovered drug has yet won full FDA approval.
Uncategorized
Takeda Signs $600 Million AI Drug Discovery Deal With Insilico Medicine
Takeda signed a $600 million AI drug discovery deal with Insilico Medicine, joining Eli Lilly and AstraZeneca in a wave of major pharma bets on AI-driven drug development in 2026.
Uncategorized
Eli Lilly Expands AI Drug Discovery Bet With $2.75 Billion Insilico Medicine Deal
Eli Lilly signed a deal worth up to $2.75 billion with Insilico Medicine to develop new drugs using AI, one of 2026's largest AI drug discovery partnerships.
Uncategorized
WellSpan Health Expands Hippocratic AI Deal to Platform-Wide Use Across Every Care Setting
WellSpan Health expanded its partnership with Hippocratic AI on July 30, 2026 into a platform-wide, multi-year deal covering inbound, outbound, ambulatory, and inpatient care, moving its Ana voice agent beyond scheduling into clinical navigation.
In-Depth
Uncategorized
AstraZeneca Signs Up to $1.5 Billion AI Drug-Discovery Deal With insitro to Target MASH and Cardiomyopathies
AstraZeneca signed an AI drug-discovery deal with insitro on October 15, 2026 worth up to $1.5 billion, targeting MASH and cardiomyopathies using insitro's Virtual Human machine-learning platform.
Uncategorized
Chai Discovery Raises $400 Million at $3.8 Billion Valuation as AI Drug Design Reaches Eli Lilly and Pfizer
Chai Discovery has raised a $400 million Series C round led by Index Ventures at a $3.8 billion valuation, nearly tripling its worth from seven months earlier as its AI-designed antibodies move into partnerships with Eli Lilly and Pfizer.
Uncategorized
OpenAI Acquires Health-Tech Startup Torch to Build ‘Unified Medical Memory’ for ChatGPT Health
OpenAI has acquired Torch, a four-person health-tech startup building a unified patient data layer for AI systems, in a deal reported at $60 million to $100 million as part of its push into consumer health products.
Uncategorized
University of Texas System to Deploy Generative AI Across All Health Institutions With Qualified Health
The University of Texas System is rolling out a generative AI chat platform and staff productivity agents across its health institutions in partnership with Qualified Health, one of the broadest academic-medicine AI deployments announced in 2026.
Uncategorized
AstraZeneca and Oracle Launch Global AI Collaboration to Speed Clinical Trials and Early Diagnosis
AstraZeneca and Oracle announced a global AI collaboration on October 20, 2026 to speed clinical trial recruitment and early diagnosis, starting with a hypertension pilot in Abu Dhabi built on deidentified real-world data.
